HLA-C and neoplasm: Sayour et al. developed innovative lipid NPs that deliver tumor-derived RNA that quickly activate a T cell response via the MHC presentation, they showed that immunocompetent mice with high-grade glioma responded to treatment with tumor-derived RNA loaded NPs [114].